Oral Magnesium Supplementation for the Prevention of Preeclampsia: a Meta-analysis or Randomized Controlled Trials

Biological Trace Element Research - Tập 200 - Trang 3572-3581 - 2021
Jing Yuan1, Ying Yu2, Tongyu Zhu3, Xiaohan Lin3, Xincheng Jing3, Juan Zhang3
1Department of Medical Information, The 960th Hospital of the People’s Liberation Army of China, Jinan, China
2Department of Obstetrics, Zhangqiu District People’s Hospital, Jinan, China
3Department of Gynecology and Obstetrics, The 960th Hospital of the People’s Liberation Army of China, Jinan, China

Tóm tắt

Previous studies evaluating the role of magnesium supplementation as a preventative strategy for preeclampsia showed inconsistent results. We performed a meta-analysis or randomized controlled trials (RCTs) to evaluate the influence of oral magnesium supplementation on the incidence of preeclampsia in pregnant women. Relevant studies were obtained by search of Medline, Embase, and Cochrane’s Library databases. A random effects model was used to pool the results. Influences of study characteristics of the outcome were evaluated by predefined subgroup analyses. Seven RCTs with 2653 pregnant women were included. Pooled results showed that oral magnesium supplementation during pregnancy significantly reduced the risk of preeclampsia (risk ratio [RR]: 0.76, 95% confidence interval [CI]: 0.59 to 0.98, P = 0.04) with no significant heterogeneity (P for Cochrane’s Q test = 0.42, I2 = 1%). The result was not significant for the outcome of severe preeclampsia (RR: 0.54, 95% CI: 0.18 to 1.69, P = 0.29; I2 = 0%), although only two studies were available. Subgroup analysis showed that oral magnesium supplementation did not significantly reduce the risk of preeclampsia in normal pregnant women (RR: 0.91, 95% CI: 0.67 to 1.25, P = 0.57), but the preventative effect was significant in studies with normal and high-risk pregnant women (RR: 0.54, 95% CI: 0.35 to 0.83, P = 0.005; P for subgroup difference = 0.04). In conclusion, oral supplementation of magnesium may reduce the risk of preeclampsia, which may be more remarkable in high-risk pregnant women.

Tài liệu tham khảo

Phipps EA, Thadhani R, Benzing T, Karumanchi SA (2019) Pre-eclampsia: pathogenesis, novel diagnostics and therapies. Nat Rev Nephrol 15(5):275–289. https://doi.org/10.1038/s41581-019-0119-6 Ives CW, Sinkey R, Rajapreyar I, Tita ATN, Oparil S (2020) Preeclampsia-pathophysiology and clinical presentations: JACC state-of-the-art review. J Am Coll Cardiol 76(14):1690–1702. https://doi.org/10.1016/j.jacc.2020.08.014 Bokslag A, van Weissenbruch M, Mol BW, de Groot CJ (2016) Preeclampsia; short and long-term consequences for mother and neonate. Early Hum Dev 102:47–50. https://doi.org/10.1016/j.earlhumdev.2016.09.007 Rana S, Lemoine E, Granger JP, Karumanchi SA (2019) Preeclampsia: pathophysiology, challenges, and perspectives. Circ Res 124(7):1094–1112. https://doi.org/10.1161/CIRCRESAHA.118.313276 Wu P, Haththotuwa R, Kwok CS, Babu A, Kotronias RA, Rushton C, Zaman A, Fryer AA, Kadam U, Chew-Graham CA, Mamas MA (2017) Preeclampsia and future cardiovascular health: a systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes 10(2). https://doi.org/10.1161/CIRCOUTCOMES.116.003497 Das NS, Dheen ST, Ling EA, Bay BH, Srinivasan DK (2019) Therapeutic prospects in preeclampsia - a mini-review. Curr Med Chem 26(25):4786–4798. https://doi.org/10.2174/0929867326666190228115423 El-Sayed AAF (2017) Preeclampsia: a review of the pathogenesis and possible management strategies based on its pathophysiological derangements. Taiwan J Obstet Gynecol 56(5):593–598. https://doi.org/10.1016/j.tjog.2017.08.004 Dalton LM, Ni Fhloinn DM, Gaydadzhieva GT, Mazurkiewicz OM, Leeson H, Wright CP (2016) Magnesium in pregnancy. Nutr Rev 74(9):549–557. https://doi.org/10.1093/nutrit/nuw018 Makrides M, Crosby DD, Bain E, Crowther CA (2014) Magnesium supplementation in pregnancy. Cochrane Database Syst Rev 4:CD000937. https://doi.org/10.1002/14651858.CD000937.pub2 Altman D, Carroli G, Duley L, Farrell B, Moodley J, Neilson J, Smith D (2002) Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet 359(9321):1877–1890. https://doi.org/10.1016/s0140-6736(02)08778-0 Sullivan M, Cunningham K, Angras K, Mackeen AD (2021) Duration of postpartum magnesium sulfate for seizure prophylaxis in women with preeclampsia: a systematic review and meta-analysis. J Matern Fetal Neonatal Med:1–6. https://doi.org/10.1080/14767058.2021.1946505 Yifu P, Lei Y, Yujin G, Xingwang Z, Shaoming L (2020) Shortened postpartum magnesium sulfate treatment vs traditional 24h for severe preeclampsia: a systematic review and meta-analysis of randomized trials. Hypertens Pregnancy 39(2):186–195. https://doi.org/10.1080/10641955.2020.1753067 Schoenaker DA, Soedamah-Muthu SS, Mishra GD (2014) The association between dietary factors and gestational hypertension and pre-eclampsia: a systematic review and meta-analysis of observational studies. BMC Med 12:157. https://doi.org/10.1186/s12916-014-0157-7 Saputri CA, Sunarno I, Usman AN, Arsyad A, Idris I (2020) Serum magnesium levels in normal pregnant women, severe preeclampsia, and severe preeclampsia with complications; a consideration for early supplementation? Enferm Clin 30(Suppl 4):532–535. https://doi.org/10.1016/j.enfcli.2019.10.133 Jafrin W, Mia AR, Chakraborty PK, Hoque MR, Paul UK, Shaha KR, Akhter S, Roy AS (2014) An evaluation of serum magnesium status in pre-eclampsia compared to the normal pregnancy. Mymensingh Med J 23(4):649–653 Kovacs L, Molnar BG, Huhn E, Bodis L (1988) Magnesium substitution in pregnancy. A prospective, randomized double-blind study. Geburtshilfe Frauenheilkd 48(8):595–600 Spatling L, Spatling G (1988) Magnesium supplementation in pregnancy. A double-blind study. Br J Obstet Gynaecol 95(2):120–125 Sibai BM, Villar MA, Bray E (1989) Magnesium supplementation during pregnancy: a double-blind randomized controlled clinical trial. Am J Obstet Gynecol 161(1):115–119. https://doi.org/10.1016/0002-9378(89)90246-9 Almeida A, Carter JP, Anatol A, Prost C (1992) Effects of a combination of evening primrose oil (gamma linolenic acid) and fish oil (eicosapentaenoic + docahexaenoic acid) versus magnesium, and versus placebo in preventing pre-eclampsia. Women Health 19(2-3):117–131. https://doi.org/10.1300/J013v19n02_07 Zarean E, Tarjan A (2017) Effect of magnesium supplement on pregnancy outcomes: a randomized control trial. Adv Biomed Res 6:109. https://doi.org/10.4103/2277-9175.213879 Bullarbo M, Mattson H, Broman AK, Odman N, Nielsen TF (2018) Magnesium supplementation and blood pressure in pregnancy: a double-blind randomized multicenter study. J Pregnancy 2018:4843159. https://doi.org/10.1155/2018/4843159 Araujo CAL, de Sousa OL, de Gusmao IMB, Guimaraes A, Ribeiro M, Alves JGB (2020) Magnesium supplementation and preeclampsia in low-income pregnant women - a randomized double-blind clinical trial. BMC Pregnancy Childbirth 20(1):208. https://doi.org/10.1186/s12884-020-02877-0 Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339:b2535. https://doi.org/10.1136/bmj.b2535 Higgins J, Green S (2011) Cochrane handbook for systematic reviews of interventions version 5.1.0. The Cochrane Collaboration www.cochranehandbook.org Bartsch E, Medcalf KE, Park AL, Ray JG (2016) Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies. BMJ 353:i1753. https://doi.org/10.1136/bmj.i1753 Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539–1558. https://doi.org/10.1002/sim.1186 Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–634 Phipps E, Prasanna D, Brima W, Jim B (2016) Preeclampsia: updates in pathogenesis, definitions, and guidelines. Clin J Am Soc Nephrol 11(6):1102–1113. https://doi.org/10.2215/CJN.12081115 Giachini FR, Galaviz-Hernandez C, Damiano AE, Viana M, Cadavid A, Asturizaga P, Teran E, Clapes S, Alcala M, Bueno J, Calderon-Dominguez M, Ramos MP, Lima VV, Sosa-Macias M, Martinez N, Roberts JM, Escudero C (2017) Vascular dysfunction in mother and offspring during preeclampsia: contributions from Latin-American countries. Curr Hypertens Rep 19(10):83. https://doi.org/10.1007/s11906-017-0781-7 Cornelius DC, Cottrell J, Amaral LM, LaMarca B (2019) Inflammatory mediators: a causal link to hypertension during preeclampsia. Br J Pharmacol 176(12):1914–1921. https://doi.org/10.1111/bph.14466 Boeldt DS, Bird IM (2017) Vascular adaptation in pregnancy and endothelial dysfunction in preeclampsia. J Endocrinol 232(1):R27–R44. https://doi.org/10.1530/JOE-16-0340 Simental-Mendia LE, Sahebkar A, Rodriguez-Moran M, Zambrano-Galvan G, Guerrero-Romero F (2017) Effect of magnesium supplementation on plasma C-reactive protein concentrations: a systematic review and meta-analysis of randomized controlled trials. Curr Pharm Des 23(31):4678–4686. https://doi.org/10.2174/1381612823666170525153605 Marques B, Klein M, da Cunha MR, de Souza MS, de Paula NL, de Paula T, Correa FM, Oigman W, Neves MF (2020) Effects of oral magnesium supplementation on vascular function: a systematic review and meta-analysis of randomized controlled trials. High Blood Press Cardiovasc Prev 27(1):19–28. https://doi.org/10.1007/s40292-019-00355-z Darooghegi Mofrad M, Djafarian K, Mozaffari H, Shab-Bidar S (2018) Effect of magnesium supplementation on endothelial function: a systematic review and meta-analysis of randomized controlled trials. Atherosclerosis 273:98–105. https://doi.org/10.1016/j.atherosclerosis.2018.04.020 Dibaba DT, Xun P, Song Y, Rosanoff A, Shechter M, He K (2017) The effect of magnesium supplementation on blood pressure in individuals with insulin resistance, prediabetes, or noncommunicable chronic diseases: a meta-analysis of randomized controlled trials. Am J Clin Nutr 106(3):921–929. https://doi.org/10.3945/ajcn.117.155291 Sadeghian M, Azadbakht L, Khalili N, Mortazavi M, Esmaillzadeh A (2020) Oral magnesium supplementation improved lipid profile but increased insulin resistance in patients with diabetic nephropathy: a double-blind randomized controlled clinical trial. Biol Trace Elem Res 193(1):23–35. https://doi.org/10.1007/s12011-019-01687-6 Hosgorler F, Kizildag S, Ates M, Argon A, Koc B, Kandis S, Guvendi G, Ilgin R, Uysal N (2020) The chronic use of magnesium decreases VEGF levels in the uterine tissue in rats. Biol Trace Elem Res 196(2):545–551. https://doi.org/10.1007/s12011-019-01944-8 Jena MK, Sharma NR, Petitt M, Maulik D, Nayak NR (2020) Pathogenesis of preeclampsia and therapeutic approaches targeting the placenta. Biomolecules 10(6). https://doi.org/10.3390/biom10060953 Rolnik DL, Nicolaides KH, Poon LC (2020) Prevention of preeclampsia with aspirin. Am J Obstet Gynecol. https://doi.org/10.1016/j.ajog.2020.08.045